Trials / Active Not Recruiting
Active Not RecruitingNCT07454148
CART-BP Prospective Study for Hypertension Control
Efficacy and Safety of Cuffless Ambulatory Blood Pressure Monitoring Device-Guided Blood Pressure Management in Korean Patients With Uncontrolled Hypertension: A Prospective Non-Randomized Study
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 288 (actual)
- Sponsor
- Korea University Anam Hospital · Academic / Other
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
This prospective, open-label, non-randomized study evaluates the effectiveness and safety of a CART BP pro(a brand name of cuffless ambulatory blood pressure monitoring device)-guided blood pressure management strategy in Korean patients with uncontrolled hypertension. Participants are allocated to either a CART BP pro-guided management group or a usual care group based on clinical decision and participant preference. The primary efficacy endpoint is 24-hour mean ambulatory systolic blood pressure at 24 weeks; safety outcomes including treatment-emergent adverse events (TEAEs) are also assessed.
Detailed description
Hypertension remains suboptimally controlled despite combination pharmacotherapy, and office blood pressure measurements may not adequately reflect true ambulatory blood pressure burden and nocturnal patterns. CART BP pro is a wearable, cuffless photoplethysmography-based continuous blood pressure monitoring device. This study investigates whether a CART BP pro-guided antihypertensive titration strategy improves 24-hour ambulatory blood pressure control compared with usual care in real-world outpatient settings. Participants receive standard antihypertensive medications (e.g., angiotensin receptor blocker \[ARB\], calcium channel blocker \[CCB\], thiazide diuretic) per guideline-based care. In the CART BP pro-guided group, medication adjustments are informed by CART BP pro-derived 24-hour blood pressure data. Follow-up is 24 weeks with optional extended follow-up to 48 weeks.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | CART BP pro | Wearable cuffless continuous blood pressure monitoring device. |
| OTHER | Usual care (office BP-based management) | Standard hypertension management based on office blood pressure. |
Timeline
- Start date
- 2025-03-25
- Primary completion
- 2026-05-04
- Completion
- 2026-05-04
- First posted
- 2026-03-06
- Last updated
- 2026-03-10
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT07454148. Inclusion in this directory is not an endorsement.